Clinical Yield of Laboratory Monitoring During Ritlecitinib Treatment for Alopecia Areata: A Prospective Real-World Cohort Study

J. Huang, Z. Zhang, J. Jian, M. Li, T. Tian, S. Zhang, K. Yang, R. Ji, F. Liu, Z. Zhao, Y. Tang, W. Shi, and J. Li

doi:10.1016/j.jaad.2026.07.089

Abstract

Routine laboratory monitoring is recommended during JAK inhibitor therapy, but its clinical yield in patients with alopecia areata has not been prospectively characterized.

← Back to publications